Clarity Financial LLC Discloses $1B Portfolio in Q3 13F Filing
Clarity Financial LLC
Filing Summary
Clarity Financial LLC Discloses $1B Portfolio in Q3 13F Filing
Filer: Clarity Financial LLC CIK: 0001862145 Form: 13F-HR | Filed: 2025-10-10 Significance: Medium
Portfolio Summary: • Total Value: $1,007,548,187 • Number of Holdings: 119 • Period of Report: 2025-09-30
Top 5 Holdings (by value):
- iShares 3-7 Year Treasury Bond ETF ($157.3M)
- AbbVie Inc. ($47.7M)
- Berkshire Hathaway Inc. ($37.9M)
- Microsoft Corp. ($37.0M)
- Alphabet Inc. ($35.8M)
Key Insight: Clarity Financial's Q3 portfolio reveals a significant allocation to fixed income ETFs, with its largest single position in mid-term treasury bonds. This is balanced by major stakes in large-cap healthcare, technology, and financial companies, suggesting a balanced growth and capital preservation strategy.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Clarity Financial LLC (13F-HR)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: Clarity Financial LLC has reported assets under management (AUM) of over $1 billion as of Q3 2025. The portfolio's largest holding is a mid-term Treasury bond ETF, indicating a significant focus on capital preservation and fixed income, balanced with substantial positions in mega-cap technology, healthcare, and financial stocks.
- Market Impact: As a standard quarterly disclosure, this filing is unlikely to cause significant, immediate market volatility in the underlying securities. However, it provides valuable insight into the strategic positioning of a billion-dollar fund, contributing to the broader picture of institutional sentiment.
Filer Information
| Field | Value |
|---|---|
| Company | Clarity Financial LLC |
| Ticker Symbol | Not Applicable (Private) |
| CIK | 0001862145 |
| Total AUM Reported | $1,007,548,187 |
Insider Information
This section is not applicable. Form 13F-HR is a quarterly report of holdings filed by an institutional investment manager, not an insider transaction report (like Form 4).
Portfolio Summary
| Field | Value |
|---|---|
| Form Type | 13F-HR (Holdings Report) |
| Period of Report Date | 2025-09-30 |
| Total Holdings Value | $1,007,548,187 |
| Number of Holdings | 119 |
Top 10 Holdings by Value
- ISHARES TR (3 7 YR TREAS BD): $157,320,713
- ABBVIE INC: $47,663,603
- BERKSHIRE HATHAWAY INC DEL (CL B): $37,901,040
- MICROSOFT CORP: $37,040,213
- ALPHABET INC (CAP STK CL C): $35,802,069
- COSTCO WHSL CORP NEW: $31,730,835
- NVIDIA CORPORATION: $31,693,502
- PALANTIR TECHNOLOGIES INC: $31,397,988
- ELI LILLY & CO: $28,745,186
- SELECT SECTOR SPDR TR (TECHNOLOGY): $29,086,595
Market Impact Analysis
Sentiment Indicator: Neutral to Cautiously Bullish
- Reasoning: The portfolio's structure suggests a dual strategy. The massive allocation to a Treasury bond ETF ($157M) points to a defensive stance and a desire for stable returns amidst potential market uncertainty. Simultaneously, the large, concentrated bets on high-growth technology (Microsoft, Alphabet, NVIDIA, Palantir) and stable large-caps (AbbVie, Berkshire, Costco) indicate a bullish long-term outlook on specific market leaders.
Sector Allocation Insights
- Fixed Income & ETFs: The portfolio is heavily weighted towards ETFs, particularly bond ETFs, which comprise the largest single position. This strategy provides diversification and liquidity.
- Technology: A clear high-conviction area, with major individual holdings in MSFT, GOOGL, NVDA, and PLTR, plus a large position in the Technology Select Sector SPDR Fund (XLK).
- Healthcare: Strong presence with AbbVie and Eli Lilly in the top 10, indicating a bullish view on the pharmaceutical sector.
- Consumer Staples/Discretionary: Significant holdings in Procter & Gamble and Costco show a belief in the resilience of the consumer.
Investment Insights
Key Takeaways
- Balanced Strategy: Clarity Financial is not making an all-out bet on growth. The firm is balancing high-conviction equity positions with a very large, conservative allocation to fixed income.
- Concentration in Leaders: The equity portfolio is concentrated in well-established, mega-cap leaders across technology, healthcare, and finance. This is a common strategy for large funds seeking quality and scale.
- ETF Utilization: The extensive use of ETFs for exposure to bonds and broad market sectors (like the S&P 500 and various sector SPDRs) highlights a strategy focused on managing risk through diversification while making specific bets on individual stocks.
Contextual Analysis
Filing Significance
This 13F filing provides a transparent, albeit delayed, look into the investment decisions of a significant market participant. For investors tracking institutional money flows, this data is a valuable piece of the puzzle for understanding which stocks and sectors are attracting capital from large managers.
Economic Context
Filed for the period ending September 30, 2025, this portfolio reflects a strategy formulated during the third quarter of the year. The heavy allocation to bonds may reflect prevailing interest rate expectations or macroeconomic uncertainty during that period.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-10 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
